Home Cart 0 Sign in  
X

[ CAS No. 146137-74-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 146137-74-8
Chemical Structure| 146137-74-8
Chemical Structure| 146137-74-8
Structure of 146137-74-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 146137-74-8 ]

Related Doc. of [ 146137-74-8 ]

Alternatived Products of [ 146137-74-8 ]

Product Details of [ 146137-74-8 ]

CAS No. :146137-74-8 MDL No. :MFCD01090998
Formula : C8H7FO2 Boiling Point : -
Linear Structure Formula :- InChI Key :UIOAYOIJMYMOEU-UHFFFAOYSA-N
M.W : 154.14 Pubchem ID :2737357
Synonyms :

Calculated chemistry of [ 146137-74-8 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 38.28
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.2 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.61
Log Po/w (XLOGP3) : 1.46
Log Po/w (WLOGP) : 2.07
Log Po/w (MLOGP) : 1.55
Log Po/w (SILICOS-IT) : 2.39
Consensus Log Po/w : 1.82

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.99
Solubility : 1.59 mg/ml ; 0.0103 mol/l
Class : Very soluble
Log S (Ali) : -1.62
Solubility : 3.71 mg/ml ; 0.0241 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.74
Solubility : 0.282 mg/ml ; 0.00183 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.27

Safety of [ 146137-74-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 146137-74-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 146137-74-8 ]
  • Downstream synthetic route of [ 146137-74-8 ]

[ 146137-74-8 ] Synthesis Path-Upstream   1~16

  • 1
  • [ 146137-74-8 ]
  • [ 38226-10-7 ]
Reference: [1] Patent: US2004/106653, 2004, A1, . Location in patent: Page/Page column 42
[2] Patent: WO2004/45610, 2004, A1, . Location in patent: Page/Page column 137-138
  • 2
  • [ 2591-86-8 ]
  • [ 456-49-5 ]
  • [ 331-64-6 ]
  • [ 146137-74-8 ]
Reference: [1] Journal of Medicinal Chemistry, 1988, vol. 31, # 1, p. 72 - 83
  • 3
  • [ 50-00-0 ]
  • [ 372-20-3 ]
  • [ 77-78-1 ]
  • [ 450-83-9 ]
  • [ 146137-74-8 ]
YieldReaction ConditionsOperation in experiment
15.8 g
Stage #1: With magnesium chloride In acetonitrile for 0.0833333 h; Inert atmosphere; Molecular sieve
Stage #2: for 0.5 h; Inert atmosphere; Molecular sieve
The m-fluorophenol (20g, 0.2πο1) was dissolved in acetonitrile (500mL, dried over molecular sieves), protected by argon and anhydrous magnesium chloride (102g, l.lmol) was added with stirring. 5min. Triethylamine (225 mL, 1.6 mol) was added and the mixture was exothermic. After stirring for 30 min, paraformaldehyde (63 g, purchased from aldrich company, the same below) was added and reacted at 50 ° C. for 3 h. Finished reaction. 1N aqueous hydrochloric acid was added to adjust the pH to 4, and the mixture was extracted with ethyl acetate (3 × 150 mL). The combined organic phases were dried over anhydrous magnesium sulfate and the solvent was evaporated under reduced pressure (water chestnut) to give the crude product as a dark red oil B-la and aldehyde by-product) 49.9g, set curing. The crude product was dissolved in tetrahydrofuran (100 mL) and potassium carbonate (81.2 g, 0.6 mol) and dimethyl sulfate (25.4 mL, 0.3 mol) were added and reacted at 40 ° C overnight ), TLC showed the raw material has disappeared. The potassium carbonate was filtered off and the solid was washed with ethyl acetate (3 × 100 mL). The organic phases were combined, dried over anhydrous magnesium sulfate and concentrated. The residue was purified by column chromatography (using a 15: 1 volume ratio of ro / Et0Ac as eluant) Intermediate B-2a (15.8 g) and by-product 2-fluoro-6-methoxybenzaldehyde (2.8 g) all in the form of a light yellow solid with a total yield of 68percent 0B-2a: Mp: ° C; 6h (300ΜΗζ; CDC13) 10.4 (1Η, s), 7.85 (1Η, dd, J = 8.4Hz, 6.9Ηζ), 6.75-6.67 (2H, m), 3.93 (d, J = 11.0Ηζ), 130.9 (d, J = 11.6Ηζ), 121.6 (d, J = , J = 2.7Hz), 108.1 (d, J = 22.1Ηζ), 99.7 (d, J = 25.7Ηζ), 56.0.2-Fluoro-6-methoxy- benzaldehyde: Μρ: 60-61 ° C ; 6H (300 MΗζ; CDC13) 10.3 (1H, s), 7.41 (1H, dd, J = 15.0Ηζ, 8.4Ηζ), 6.71-6.61 (2H, m), 3.85 (3H, s) CDC13) 187.4 (d, J = 3.4 Hz), 163.3 (dJc, F = 260.5 Hz), 162.2 (d, J = 5.4Ηζ), 136.2 (d, J = 12.0Ηζ), 114.0 ), 108.6 (d, J = 21.3 Hz), 107.3 (d, J = 3.5Ηζ), 56.3.
Reference: [1] European Journal of Organic Chemistry, 2016, vol. 2016, # 7, p. 1429 - 1438
[2] Patent: CN104557654, 2017, B, . Location in patent: Paragraph 0086-0088
  • 4
  • [ 146137-74-8 ]
  • [ 94088-46-7 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1997, vol. 34, # 4, p. 1163 - 1172
[2] Biochemical Pharmacology, 2015, vol. 96, # 2, p. 93 - 106
  • 5
  • [ 146137-74-8 ]
  • [ 137654-21-8 ]
Reference: [1] Journal of Organic Chemistry, 2000, vol. 65, # 12, p. 3738 - 3753
[2] Organic Letters, 1999, vol. 1, # 9, p. 1491 - 1494
  • 6
  • [ 456-49-5 ]
  • [ 68-12-2 ]
  • [ 146137-74-8 ]
YieldReaction ConditionsOperation in experiment
95%
Stage #1: With n-butyllithium; diisopropylamine In tetrahydrofuran; hexane at -78℃; for 1 h;
Stage #2: for 1 h;
Stage #3: With hydrogenchloride; water In tetrahydrofuran; hexane
Intermediate 1
2-fluoro-6-methoxybenzaldehyde:
n-BuLi (1.6M in hexane, 74.3 ml, 0.118 mol) was added dropwise to a solution of diisopropylamine (13.23 g, 0.130 mol) in THF (50 ml) at 0° C., maintained for 15 min and cooled to -78° C. 3-Fluoroanisole (15 g, 0.118 mol) in THF (5° ml) was added, stirred at -78° C. for 1 h, and N,N-dimethylformamide (6.75 ml) was added and stirred for further 1 h.
The reaction mixture was quenched with 2N HCl solution and extracted with ethyl acetate.
The organic layer was dried over sodium sulphate and concentrated to afford the title compound as a red waxy solid (17.45 g, 95percent) which was used without purification in the next step.
Reference: [1] Patent: US2012/289496, 2012, A1, . Location in patent: Page/Page column 100
[2] Chemistry - A European Journal, 2015, vol. 21, # 29, p. 10322 - 10325
[3] Tetrahedron Letters, 1992, vol. 33, # 49, p. 7499 - 7502
[4] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 12, p. 2998 - 3001
[5] Patent: WO2012/151525, 2012, A1, . Location in patent: Page/Page column 100; 101
[6] Tetrahedron Letters, 2013, vol. 54, # 45, p. 6053 - 6056
[7] Journal of Agricultural and Food Chemistry, 2017, vol. 65, # 51, p. 11170 - 11178
  • 7
  • [ 94088-46-7 ]
  • [ 146137-74-8 ]
Reference: [1] Journal of Organic Chemistry, 2000, vol. 65, # 12, p. 3738 - 3753
[2] Organic Letters, 1999, vol. 1, # 9, p. 1491 - 1494
  • 8
  • [ 3030-47-5 ]
  • [ 456-49-5 ]
  • [ 146137-74-8 ]
Reference: [1] Patent: US2002/156081, 2002, A1,
[2] Patent: US6921763, 2005, B2,
  • 9
  • [ 456-49-5 ]
  • [ 146137-74-8 ]
Reference: [1] Patent: US5935973, 1999, A,
  • 10
  • [ 50-00-0 ]
  • [ 372-20-3 ]
  • [ 77-78-1 ]
  • [ 450-83-9 ]
  • [ 146137-74-8 ]
YieldReaction ConditionsOperation in experiment
15.8 g
Stage #1: With magnesium chloride In acetonitrile for 0.0833333 h; Inert atmosphere; Molecular sieve
Stage #2: for 0.5 h; Inert atmosphere; Molecular sieve
The m-fluorophenol (20g, 0.2πο1) was dissolved in acetonitrile (500mL, dried over molecular sieves), protected by argon and anhydrous magnesium chloride (102g, l.lmol) was added with stirring. 5min. Triethylamine (225 mL, 1.6 mol) was added and the mixture was exothermic. After stirring for 30 min, paraformaldehyde (63 g, purchased from aldrich company, the same below) was added and reacted at 50 ° C. for 3 h. Finished reaction. 1N aqueous hydrochloric acid was added to adjust the pH to 4, and the mixture was extracted with ethyl acetate (3 × 150 mL). The combined organic phases were dried over anhydrous magnesium sulfate and the solvent was evaporated under reduced pressure (water chestnut) to give the crude product as a dark red oil B-la and aldehyde by-product) 49.9g, set curing. The crude product was dissolved in tetrahydrofuran (100 mL) and potassium carbonate (81.2 g, 0.6 mol) and dimethyl sulfate (25.4 mL, 0.3 mol) were added and reacted at 40 ° C overnight ), TLC showed the raw material has disappeared. The potassium carbonate was filtered off and the solid was washed with ethyl acetate (3 × 100 mL). The organic phases were combined, dried over anhydrous magnesium sulfate and concentrated. The residue was purified by column chromatography (using a 15: 1 volume ratio of ro / Et0Ac as eluant) Intermediate B-2a (15.8 g) and by-product 2-fluoro-6-methoxybenzaldehyde (2.8 g) all in the form of a light yellow solid with a total yield of 68percent 0B-2a: Mp: ° C; 6h (300ΜΗζ; CDC13) 10.4 (1Η, s), 7.85 (1Η, dd, J = 8.4Hz, 6.9Ηζ), 6.75-6.67 (2H, m), 3.93 (d, J = 11.0Ηζ), 130.9 (d, J = 11.6Ηζ), 121.6 (d, J = , J = 2.7Hz), 108.1 (d, J = 22.1Ηζ), 99.7 (d, J = 25.7Ηζ), 56.0.2-Fluoro-6-methoxy- benzaldehyde: Μρ: 60-61 ° C ; 6H (300 MΗζ; CDC13) 10.3 (1H, s), 7.41 (1H, dd, J = 15.0Ηζ, 8.4Ηζ), 6.71-6.61 (2H, m), 3.85 (3H, s) CDC13) 187.4 (d, J = 3.4 Hz), 163.3 (dJc, F = 260.5 Hz), 162.2 (d, J = 5.4Ηζ), 136.2 (d, J = 12.0Ηζ), 114.0 ), 108.6 (d, J = 21.3 Hz), 107.3 (d, J = 3.5Ηζ), 56.3.
Reference: [1] European Journal of Organic Chemistry, 2016, vol. 2016, # 7, p. 1429 - 1438
[2] Patent: CN104557654, 2017, B, . Location in patent: Paragraph 0086-0088
  • 11
  • [ 137654-21-8 ]
  • [ 146137-74-8 ]
Reference: [1] Patent: WO2014/52365, 2014, A1,
  • 12
  • [ 2591-86-8 ]
  • [ 456-49-5 ]
  • [ 331-64-6 ]
  • [ 146137-74-8 ]
Reference: [1] Journal of Medicinal Chemistry, 1988, vol. 31, # 1, p. 72 - 83
  • 13
  • [ 146137-74-8 ]
  • [ 93339-98-1 ]
Reference: [1] Patent: WO2012/151525, 2012, A1,
[2] Patent: US2012/289496, 2012, A1,
  • 14
  • [ 146137-74-8 ]
  • [ 351210-06-5 ]
Reference: [1] Journal of Organic Chemistry, 2006, vol. 71, # 21, p. 8166 - 8172
[2] Journal of Organic Chemistry, 2009, vol. 74, # 16, p. 6331 - 6334
[3] Journal of Organic Chemistry, 2006, vol. 71, # 21, p. 8166 - 8172
  • 15
  • [ 146137-74-8 ]
  • [ 120484-50-6 ]
Reference: [1] Patent: WO2012/151525, 2012, A1,
[2] Patent: US2012/289496, 2012, A1,
[3] Journal of the American Chemical Society, 2016, vol. 138, # 5, p. 1486 - 1489
  • 16
  • [ 773837-37-9 ]
  • [ 146137-74-8 ]
  • [ 500912-18-5 ]
YieldReaction ConditionsOperation in experiment
46% at 80℃; for 4 h; To a solution of Scheme 56 compound 3 (5.7 g, 26.15 mmol) in dry EtOH (70 mL) was added NaCN (1.4 g, 28.76 mmol) and the reaction mixture was stirred at 80 °C for 4 h. After TLC showed the starting material was completely consumed, the reaction mixture was concentrated to give a crude compound which was diluted with ice water (30 mL) and extracted with EtOAc (2 x 50 mL). The organic layer was washed with brine (20 mL), dried over Na2S04 and concentrated to give a residue which was purified by column chromatography (eluting with petroleum ether/EtOAc 100/0 gradually increasing to 60/40) to give Scheme 56 compound 4 (2.0 g, 46percent) as a colorless liquid. MS [ESI, MH+] = 166.06.
Reference: [1] Patent: WO2014/52365, 2014, A1, . Location in patent: Page/Page column 299-300
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 146137-74-8 ]

Fluorinated Building Blocks

Chemical Structure| 187543-87-9

[ 187543-87-9 ]

2,3-Difluoro-6-methoxybenzaldehyde

Similarity: 0.95

Chemical Structure| 105728-90-3

[ 105728-90-3 ]

2-Fluoro-5-methoxybenzaldehyde

Similarity: 0.94

Chemical Structure| 120484-50-6

[ 120484-50-6 ]

1-(2-Fluoro-6-methoxyphenyl)ethanone

Similarity: 0.90

Chemical Structure| 256417-10-4

[ 256417-10-4 ]

2,6-Difluoro-4-methoxybenzaldehyde

Similarity: 0.89

Chemical Structure| 136516-64-8

[ 136516-64-8 ]

2,4-Difluoro-6-hydroxybenzaldehyde

Similarity: 0.89

Aryls

Chemical Structure| 187543-87-9

[ 187543-87-9 ]

2,3-Difluoro-6-methoxybenzaldehyde

Similarity: 0.95

Chemical Structure| 105728-90-3

[ 105728-90-3 ]

2-Fluoro-5-methoxybenzaldehyde

Similarity: 0.94

Chemical Structure| 120484-50-6

[ 120484-50-6 ]

1-(2-Fluoro-6-methoxyphenyl)ethanone

Similarity: 0.90

Chemical Structure| 256417-10-4

[ 256417-10-4 ]

2,6-Difluoro-4-methoxybenzaldehyde

Similarity: 0.89

Chemical Structure| 136516-64-8

[ 136516-64-8 ]

2,4-Difluoro-6-hydroxybenzaldehyde

Similarity: 0.89

Aldehydes

Chemical Structure| 187543-87-9

[ 187543-87-9 ]

2,3-Difluoro-6-methoxybenzaldehyde

Similarity: 0.95

Chemical Structure| 105728-90-3

[ 105728-90-3 ]

2-Fluoro-5-methoxybenzaldehyde

Similarity: 0.94

Chemical Structure| 256417-10-4

[ 256417-10-4 ]

2,6-Difluoro-4-methoxybenzaldehyde

Similarity: 0.89

Chemical Structure| 136516-64-8

[ 136516-64-8 ]

2,4-Difluoro-6-hydroxybenzaldehyde

Similarity: 0.89

Chemical Structure| 879093-08-0

[ 879093-08-0 ]

2,5-Difluoro-4-methoxybenzaldehyde

Similarity: 0.86

Ethers

Chemical Structure| 187543-87-9

[ 187543-87-9 ]

2,3-Difluoro-6-methoxybenzaldehyde

Similarity: 0.95

Chemical Structure| 105728-90-3

[ 105728-90-3 ]

2-Fluoro-5-methoxybenzaldehyde

Similarity: 0.94

Chemical Structure| 120484-50-6

[ 120484-50-6 ]

1-(2-Fluoro-6-methoxyphenyl)ethanone

Similarity: 0.90

Chemical Structure| 256417-10-4

[ 256417-10-4 ]

2,6-Difluoro-4-methoxybenzaldehyde

Similarity: 0.89

Chemical Structure| 879093-08-0

[ 879093-08-0 ]

2,5-Difluoro-4-methoxybenzaldehyde

Similarity: 0.86